Skip to main content
John Rinehart, MD, Oncology, Lexington, KY, UK HealthCare Good Samaritan Hospital

JohnJosephRinehartMD

Oncology Lexington, KY

Professor, Medicine University of Kentucky College of Medicine Lexington, Kentucky

Are you Dr. Rinehart?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 75 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. John Rinehart, MD is an oncologist in Lexington, Kentucky. He is currently licensed to practice medicine in Kentucky, Alabama, and Texas. He is affiliated with UK HealthCare Good Samaritan Hospital and is a Professor at Kentucky.

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 1972 - 1974
  • University of Chicago Medical Center
    University of Chicago Medical CenterResidency, Internal Medicine, 1971 - 1972
  • Ohio State University Hospital
    Ohio State University HospitalInternship, Internal Medicine, 1970 - 1971
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1970

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2004 - 2022
  • AL State Medical License
    AL State Medical License 1999 - 2004
  • TX State Medical License
    TX State Medical License 1991 - 2003
  • OH State Medical License
    OH State Medical License 1970 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Dexamethasone/Carboplatin/Gemcitabine Untreated NsclcNational Center For Research Resources2004
  • Core--Clinical TrialsNational Cancer Institute2000–2002
  • Clinical Oncology Research Career Development ProgramNational Cancer Institute2000–2002
  • Trial Of L-377202 Once Every Three WeeksNational Center For Research Resources2000
  • Scott And White Community Clinical Oncology ProgramNational Cancer Institute1997
  • Southwest Oncology GroupNational Cancer Institute1993–1997
  • Chemotherapy And Biologics In A Murine Tumor ModelNational Cancer Institute1991
  • Phase IB Trial Of IL-2 Alone Or With Cytotoxic CellsDivision Of Cancer Treatment1988–1990

Professional Memberships

Hospital Affiliations